You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aprepitant

Showing 51 - 75 of 207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chemo Induced Nausea and Vomiting Pediatric Cancer Patients Trial in Shanghai (Fosaprepitant, Placebo(normal saline))

Not yet recruiting
  • Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients
  • Shanghai, China
    Shanghai Children's Medical Center
Jan 28, 2022

Chemo-induced Nausea and Vomiting Trial in Chengdu (5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Mar 27, 2023

Chemo-induced Nausea and Vomiting Trial in New Delhi (Ondansetron, Dexamethasone, Aprepitant)

Completed
  • Chemotherapy-induced Nausea and Vomiting
  • New Delhi, Delhi, India
    Dr Bra Irch, Aiims, New Delhi
Aug 19, 2019

Healthy Trial in Rochester (Aprepitant, Placebo)

Completed
  • Healthy
  • Aprepitant
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 10, 2018

Idiopathic Parkinson Disease Trial in Farmington Hills (CTC-413)

Unknown status
  • Idiopathic Parkinson Disease
  • CTC-413
  • Farmington Hills, Michigan
    Quest Research
Apr 9, 2019

Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant Trial in Stanford (Aromatherapy Inhaler)

Not yet recruiting
  • Cancer Distress
  • +3 more
  • Aromatherapy Inhaler
  • Stanford, California
    Aubrey Florom-smith
Aug 8, 2022

Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant , Tropisetron and Olanzapine
  • Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
  • Henan, Henan, China
  • +1 more
Apr 11, 2022

Postoperative Nausea and Vomiting, Anesthesia Complication, Thoracic Diseases Trial (Ondansetron 8mg, Fosaprepitant 150 mg)

Not yet recruiting
  • Postoperative Nausea and Vomiting
  • +2 more
  • Ondansetron 8mg
  • Fosaprepitant 150 mg
  • (no location specified)
Jun 4, 2023

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemo Trial (HR20013 for injection;dexamethasone, fosaprepitant

Not yet recruiting
  • Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
  • HR20013 for injection；dexamethasone
  • fosaprepitant dimeglumine for injection；palonosetron hydrochloride injection；dexamethasone
  • (no location specified)
Aug 19, 2022

Postoperative Nausea and Vomiting Trial in Hershey (2% Lidocaine HCl topical solution, 0.9% Sodium chloride)

Withdrawn
  • Postoperative Nausea and Vomiting
  • 2% Lidocaine HCl topical solution
  • 0.9% Sodium chloride
  • Hershey, Pennsylvania
    Milton S. Hershey Medical Center
Dec 8, 2022

Chemo-induced Nausea and Vomiting, Lung Cancer Trial in Zunyi, Nanchong (Olanzapine, Placebos)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Lung Cancer
  • Zunyi, Guizhou, China
  • +1 more
Jul 12, 2021

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Analgesia Trial in San Antonio (HTX-011, Luer Lock applicator, Vial access device)

Completed
  • Analgesia
  • San Antonio, Texas
    Endeavor Clinical Trials, LLC
Mar 12, 2019

Chemo-induced Nausea and Vomiting Trial in Zhuhai (Olanzapine+NK-1 RA+5-HT3 RA, Dexamethasone+NK-1 RA+5-HT3 RA)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Olanzapine+NK-1 RA+5-HT3 RA
  • Dexamethasone+NK-1 RA+5-HT3 RA
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
May 17, 2021

COPD Trial in Lebanon (Aprepitant, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aprepitant
  • Placebo
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Sep 30, 2018

Pediatric Cancer Trial (Fosaprepitant, ondansetron with dexamethasone)

Not yet recruiting
  • Pediatric Cancer
  • (no location specified)
Sep 1, 2021

Bariatric Surgery Candidate, Perioperative Complication, Nausea Trial in Tehran (Metoclopramide, Ondansetron, Metoclopramide and

Completed
  • Bariatric Surgery Candidate
  • +4 more
  • Tehran, Iran, Islamic Republic of
    Loghman Hakim Hospital
Oct 21, 2021

Cancer, Tumors Trial in Korea, Republic of (ramosetron, aprepitant, dexamethasone, palonosetron, aprepitant, dexamethasone)

Completed
  • Cancer
  • Tumors
  • ramosetron, aprepitant, dexamethasone
  • palonosetron, aprepitant, dexamethasone
  • Suwon, Gyeonggi, Korea, Republic of
  • +9 more
May 8, 2018

Extrahepatic Bile Duct Cancer, Nausea, Vomiting Trial in Winston-Salem (drug, procedure, other)

Completed
Has Results
  • Extrahepatic Bile Duct Cancer
  • +5 more
  • aprepitant
  • +8 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 16, 2018

Postoperative Nausea and Vomiting Trial in Nashville (procedure, device, drug)

Completed
Has Results
  • Postoperative Nausea and Vomiting
  • Automated recommendation at the start of the case
  • +37 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 5, 2019

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus Trial in Lahore (NK-1R antagonist)

Unknown status
  • Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
  • NK-1R antagonist
  • Lahore, Punjab, Pakistan
    Bahria International Hospital
Jul 10, 2020

Nausea, Vomiting, Glioma Trial in Durham (aprepitant, ondansetron)

Completed
Has Results
  • Nausea
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
May 31, 2018

Nasopharyngeal Carcinoma Trial in Guangzhou (fosaprepitant)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 17, 2020

Gastrointestinal Cancer, Nausea Post Chemo Trial in Detroit (fosaprepitant dimeglumine)

Completed
Has Results
  • Gastrointestinal Cancer
  • Nausea Post Chemotherapy
  • fosaprepitant dimeglumine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 14, 2021